The Safety and Utility of Phenobarbital Use for the Treatment of Severe Alcohol Withdrawal Syndrome in the Medical Intensive Care Unit
Authors:
- 20 June 2018
- journal article
- research article
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 35 (9) , 844-850
Abstract
Background: Alcohol withdrawal syndrome (AWS) is a common reason for admission to a medical intensive care unit (MICU) and requires significant hospital resource utilization. Benzodiazepines are first-line therapy for AWS in many intensive care units. We propose the use of symptom-triggered phenobarbital for the treatment of AWS as a safe alternative to benzodiazepines. Methods: This was a retrospective observational study of a 4-year period, 2011 to 2015, of all patients with AWS admitted to the MICU of 1 tertiary care hospital and treated with phenobarbital. A symptom-triggered protocol was used. Resolution of AWS was assessed with the Richmond Agitation Sedation Scale to goal score of 0 to −1. The Charlson Comorbidity Index was used as an index of patient illness severity. Complications associated with phenobarbital use and/or the AWS admission were analyzed. Results: Data of 86 AWS patient encounters were analyzed. The mean Clinical Institute Withdrawal Assessment for Alcohol–Revised score of patients admitted to the MICU with AWS was 19 ± 9. The mean phenobarbital dose administered during the MICU stay was 1977.5 ± 1531.5 mg. There were a total of 17 (20%) intubations. The most frequent cause of mechanical ventilation in patients with AWS was loss of airway clearance, followed by hemodynamic instability secondary to upper gastrointestinal bleeding and the corresponding need for endoscopy. Conclusions: Sole use of phenobarbital use for control of AWS may be a safe alternative to benzodiazepines. Further study is needed to correlate phenobarbital serum levels with clinical control of AWS.Keywords
This publication has 25 references indexed in Scilit:
- Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICUAnnals of Intensive Care, 2012
- Comparison of Charlson comorbidity index with SAPS and APACHE scores for prediction of mortality following intensive careClinical Epidemiology, 2011
- A Double‐Blind Trial of Gabapentin Versus Lorazepam in the Treatment of Alcohol WithdrawalAlcohol, Clinical and Experimental Research, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care researchJournal of Critical Care, 2005
- The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trialJournal of General Internal Medicine, 2002
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Delirium tremensActa Psychiatrica Scandinavica, 1978
- Treatment of the Acute Alcohol Withdrawal State: A Comparison of Four DrugsAmerican Journal of Psychiatry, 1969
- A COMPARISON OF PROMAZINE AND PARALDEHYDE IN 175 CASES OF ALCOHOL WITHDRAWALAmerican Journal of Psychiatry, 1961